Drugs / LEO 90105
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01293383 | Mar 2011 | — | LEO Pharma | Completed | No outcome recorded |
| Phase 1 | NCT01293357 | Dec 2010 | — | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEO 90105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01293357 ↗ |
| Route | Topical | “Administration of LEO 90105 on Intact Skin” NCT01293357 ↗ |